Tapuria Niteen, Junnarkar Sameer, Abu-Amara Mahmoud, Fuller Barry, Seifalian Alexander M, Davidson Brian R
Niteen Tapuria, Sameer Junnarkar, Mahmoud Abu-amara, Barry Fuller, Alexander M Seifalian, Brian R Davidson, Department of HPB Surgery and Liver transplantation, Royal Free Hospital, London NW32QG, United Kingdom.
World J Gastroenterol. 2016 Sep 7;22(33):7518-35. doi: 10.3748/wjg.v22.i33.7518.
To investigate the hepatic microcirculatory changes due to Haemoxygenase (HO), effect of HO inhibition on remote ischemic preconditioning (RIPC) and modulation of CINC.
Eight groups of animals were studied - Sham, ischemia reperfusion injury (IRI) the animals were subjected to 45 min of hepatic ischemia followed by three hours of reperfusion, RIPC (remote ischemic preconditioning) + IRI group, remote ischemic preconditioning in sham (RIPC + Sham), PDTC + IR (Pyridodithiocarbamate, HO donor), ZnPP + RIPC + IRI (Zinc protoporphyrin prior to preconditioning), IR-24 (45 min of ischemia followed by 24 h of reperfusion), RIPC + IR-24 (preconditioning prior to IR). After 3 and 24 h of reperfusion the animals were killed by exsanguination and samples were taken.
Velocity of flow (160.83 ± 12.24 μm/s), sinusoidal flow (8.42 ± 1.19) and sinusoidal perfusion index (42.12 ± 7.28) in hepatic IR were lower (P < 0.05) in comparison to RIPC and PDTC (HO inducer). RIPC increased velocity of flow (328.04 ± 19.13 μm/s), sinusoidal flow (17.75 ± 2.59) and the sinusoidal perfusion index (67.28 ± 1.82) (P < 0.05). PDTC (HO induction) reproduced the effects of RIPC in hepatic IR. PDTC restored RBC velocity (300.88 ± 22.109 μm/s), sinusoidal flow (17.66 ± 3.71) and sinusoidal perfusion (82.33 ± 3.5) to near sham levels. ZnPP (HO inhibition) reduced velocity of flow of RBC in the RIPC group (170.74 ± 13.43 μm/s and sinusoidal flow in the RIPC group (9.46 ± 1.34). ZnPP in RIPC (60.29 ± 1.82) showed a fall in perfusion only at 180 min of reperfusion. Neutrophil adhesion in IR injury is seen in both postsinusoidal venules (769.05 ± 87.48) and sinusoids (97.4 ± 7.49). Neutrophil adhesion in RIPC + IR injury is reduced in both postsinusoidal venules (219.66 ± 93.79) and sinusoids (25.69 ± 9.08) (P < 0.05). PDTC reduced neutrophil adhesion in both postsinusoidal venules (89.58 ± 58.32) and sinusoids (17.98 ± 11.01) (P < 0.05) reproducing the effects of RIPC. ZnPP (HO inhibition) increased venular (589.04 ± 144.36) and sinusoidal neutrophil adhesion in preconditioned animals (121.39 ± 30.65) (P < 0.05). IR after 24 h of reperfusion increased venular and sinusoidal neutrophil adhesion in comparison to the early phase and was significantly reduced by RIPC. Hepatocellular cell death in IRI (80.83 ± 13.03), RIPC + IR (17.35 ± 2.47), and PTDC + IR (11.66 ± 1.17) reduced hepatocellular death. ZnPP + RIPC + IR (41.33 ± 3.07) significantly increased hepatocellular death (P < 0.05 PTDC/RIPC vs ZnPP and IR). The CINC cytokine levels in sham (101.32 ± 6.42). RIPC + sham (412.18 ± 65.24) as compared to sham (P < 0.05). CINC levels in hepatic IR were (644.08 ± 181.24). PDTC and RIPC CINC levels were significantly lower than hepatic IR (P < 0.05). HO inhibition in preconditioned animals with Zinc protoporphyrin increased serum CINC levels (521.81 ± 74.9) (P < 0.05). The serum CINC levels were high in the late phase of hepatic IR (15306 ± 1222.04). RIPC reduced CINC levels in the late phase of IR (467.46 ± 26.06), P < 0.05.
RIPC protects hepatic microcirculation by induction of HO and modulation of CINC in hepatic IR.
研究血红素加氧酶(HO)引起的肝脏微循环变化、HO抑制对远程缺血预处理(RIPC)的影响以及对趋化因子CINC的调节作用。
研究八组动物——假手术组、缺血再灌注损伤(IRI)组(动物经历45分钟肝脏缺血,随后3小时再灌注)、RIPC(远程缺血预处理)+IRI组、假手术中的远程缺血预处理(RIPC+假手术)组、PDTC+IR(吡哆二硫代氨基甲酸盐,HO供体)组、ZnPP+RIPC+IRI组(预处理前使用锌原卟啉)、IR-24组(45分钟缺血,随后24小时再灌注)、RIPC+IR-24组(IR前进行预处理)。再灌注3小时和24小时后,通过放血处死动物并采集样本。
与RIPC和PDTC(HO诱导剂)相比,肝脏IR组的血流速度(160.83±12.24μm/s)、肝血窦血流(8.42±1.19)和肝血窦灌注指数(42.12±7.28)较低(P<0.05)。RIPC增加了血流速度(328.04±19.13μm/s)、肝血窦血流(17.75±2.59)和肝血窦灌注指数(67.28±1.82)(P<0.05)。PDTC(HO诱导)在肝脏IR中重现了RIPC的作用。PDTC将红细胞速度(300.88±22.109μm/s)、肝血窦血流(17.66±3.71)和肝血窦灌注(82.33±3.5)恢复到接近假手术水平。ZnPP(HO抑制)降低了RIPC组的红细胞血流速度(170.74±13.43μm/s)和RIPC组的肝血窦血流(9.46±1.34)。RIPC中的ZnPP(60.29±1.82)仅在再灌注180分钟时显示灌注下降。在IR损伤中,肝后小静脉(769.05±87.48)和肝血窦(97.4±7.49)均可见中性粒细胞黏附。RIPC+IR损伤中,肝后小静脉(219.66±93.79)和肝血窦(25.69±9.08)的中性粒细胞黏附减少(P<0.05)。PDTC降低了肝后小静脉(89.58±58.32)和肝血窦(17.98±11.01)的中性粒细胞黏附(P<0.05),重现了RIPC的作用。ZnPP(HO抑制)增加了预处理动物的小静脉(589.04±144.36)和肝血窦中性粒细胞黏附(121.39±30.65)(P<0.05)。与早期相比,再灌注24小时后的IR增加了小静脉和肝血窦的中性粒细胞黏附,而RIPC可显著降低。IRI组(80.83±13.03)、RIPC+IR组(17.35±2.47)和PTDC+IR组(11.66±1.17)的肝细胞死亡减少。ZnPP+RIPC+IR组(41.33±3.07)显著增加了肝细胞死亡(P<0.05,PTDC/RIPC组与ZnPP和IR组相比)。假手术组(101.32±6.42)、RIPC+假手术组(412.18±65.24)的CINC细胞因子水平与假手术组相比(P<0.05)。肝脏IR组的CINC水平为(644.08±181.24)。PDTC和RIPC的CINC水平显著低于肝脏IR组(P<0.05)。用锌原卟啉对预处理动物进行HO抑制可增加血清CINC水平(521.81±74.9)(P<0.05)。肝脏IR晚期血清CINC水平较高(15306±1222.04)。RIPC降低了IR晚期的CINC水平(467.46±26.06),P<0.05。
RIPC通过诱导HO和调节肝脏IR中的CINC来保护肝脏微循环。